Platelet aggregation and quality control of platelet concentrates produced in the Amazon Blood Bank
AUTOR(ES)
Coêlho, Maria José Dantas, Monteiro, Taysa de Castro, Vasquez, Felicien Gonçalves, Silva, Kátia Luz Torres, Santos, Kleber Sandro Brasil dos, Oliveira, Viviana Maria Araújo de, Cavalcante, Francimary de Oliveira
FONTE
Revista Brasileira de Hematologia e Hemoterapia
DATA DE PUBLICAÇÃO
2011
RESUMO
BACKGROUND: The study of platelet aggregation is essential to assess in vitro platelet function by different platelet activation pathways. OBJECTIVE: To assess aggregation and biochemical parameters of random platelet concentrates produced at the Fundação HEMOAM using the quality control tests defined by law. METHODS: Whole blood samples from 80 donors and the respective platelet concentrate units were tested. Platelet concentrates were tested (platelet count, aggregation and pH) on days 1, 3 and 5 of storage. Additionally a leukocyte count was done only on day 1 and microbiological tests on day 5 of storage. Collagen and adenosine diphosphate were used as inducing agonists for platelet aggregation testing. RESULTS: Donor whole blood had normal aggregation (aggregation with adenosine diphosphate = 67% and with collagen = 78%). The median aggregation in platelet concentrates with adenosine diphosphate was low throughout storage (18% on day 1, 7% on day 3 and 6% on day 5) and the median aggregation with collagen was normal only on day 1 and low thereafter (54.4% on day 1, 20.5% on day 3 and 9% on day 5). CONCLUSION: Although the results were within the norms required by law, platelet concentrates had low aggregation rates. We suggest the inclusion of a functional assessment test for the quality control of platelet concentrates for a more effective response to platelet replacement therapy.
Documentos Relacionados
- Influence of caffeine on blood pressure and platelet aggregation
- Aggregation and disaggregation kinetics of human blood platelets: Part II. Shear-induced platelet aggregation.
- The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
- Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
- Interrelationships between Ca2+ and adenylate and guanylate cyclases in the control of platelet secretion and aggregation.